Cell Culture Consumables Market revenue to reach USD 400 Billion by 2036, says Research Nester
November 21, 2023 07:30 ET
|
Research Nester
New York, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global cell culture consumables market size is projected to grow at a CAGR of over ~23% from 2024 to 2036. The market is expected to garner a revenue...
South Africa Biopharmaceuticals Market Outlook & Forecasts Report 2023-2028 Featuring Key Vendors - AbbVie, F. Hoffmann-la Roche, GSK, J&J, Merck, Novartis, Novo Nordisk, Pfizer, & Sanofi
August 25, 2023 08:38 ET
|
Research and Markets
Dublin, Aug. 25, 2023 (GLOBE NEWSWIRE) -- The "South Africa Biopharmaceuticals Market - Industry Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. ...
Global Contract Manufacturing Market Report 2023: Sector is Expected to Reach $512.74 Billion by 2030 at a CAGR of 9.58%
May 05, 2023 08:43 ET
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Global Contract Manufacturing Market Size, Trends, and Growth Opportunity, by Product, by End-user, by Distribution Channel by Region and Forecast to...
The Worldwide Fill Finish Manufacturing Industry is Expected to Reach $16.1 Billion by 2028
January 13, 2023 04:18 ET
|
Research and Markets
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Fill Finish Manufacturing Market Size, Share & Industry Trends Analysis Report by End-user, Product, Regional Outlook and Forecast,...
Rentschler Biopharma appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board
November 16, 2022 04:00 ET
|
Rentschler Biopharma SE
Company increases focus on core operationsChristiane Bardroff to head global clinical and commercial manufacturing, engineering and technology operations, as well as production automation LAUPHEIM,...
Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm
September 22, 2021 07:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and ULM, Germany, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...
Rentschler Biopharma breaks ground at new U.S. production site in greater Boston
August 12, 2021 08:00 ET
|
Rentschler Biopharma SE
New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...